Structuring transactions and negotiating and drafting commercial and transactional agreements are at the heart of HBC Avocats’ healthcare and life sciences practice. The practice group is co-led by experienced partners Jonathan Burnham, who has a high level of experience and knowledge in licensing, partnership and clinical trial agreements, and Erwan Cossé, who specialises in M&A and venture capital transactions. Fabrice Herbin is also a key name to note.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Sector knowledge
Client satisfaction: NPS ®
Testimonials
Collated independently by Legal 500 research team.
- ‘Erwan Cossé played a pivotal role in defining the restructuring and management of our company. Highly responsive in every respect, he answered all requests with kindness, tact, and absolute excellence. He advised the company on legal matters and contributed to our market competitiveness. Furthermore, he was always attentive to numerous points and was a pillar of the company's strategy.'
- 'HBC Avocats utilizes the latest technologies and offers competitive advantages for the work performed, from contract drafting and negotiation to execution.'
- ‘Erwan Cossé is very experienced and able to provide to-the-point and practical legal advice.’
- 'Fabrice Herbin has the client's best interests at heart and holds firm where we might sometimes be ready to give up in order to finalize a contract.’
- ‘Jonathan Burnham is very experienced and often comes up with proposals that are interesting both legally and business-wise.'
- 'The respect and dedication of the entire team are exemplary, and their respectful approach to confidentiality, ethics, and best practices is something I have personally experienced firsthand.'
Key clients
- Orano Med
- DNA Script
- HepaRegeniX
- MedInSights
- VivAdju
- Axplora
- Novasep
- Eligo Bioscience
- Onward Therapeutics
- Emercell
- Theranexus
- OSE Immunotherapeutics
Work highlights
Advised Theranexus on structuring, drafting and negotiating a licence and supply agreement with Exeltis (part of the Insud Pharma Group).
Advised Genoskin on negotiating and drafting the investment and shareholders' agreements for its 5 M€ equity round backed by a syndicate of leading investors, including OCCTE and Captech Santé.
Advised Austral Diagnostics on negotiating and drafting the investment and shareholders' agreements for its 2.5 M€ equity seed round backed by a syndicate of leading life science investors, including Audacia and Sorbonne Venture.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Jonathan Burnham; Erwan Cossé
Other key lawyers
Fabrice Herbin